MADISON, Wis., June 8, 2021 – Cellular Logistics has joined Forward BIOLABS, a non-profit, co-working life science lab for an early-stage biotech. Forward BIOLABS life science laboratories are fully equipped, maintained, supported, and come with introductions, training, and networking that help startups grow. It was founded...
MADISON, Wis., March 09, 2021 – Cellular Logistics has been awarded a $321,000 SBIR grant from the National Institutes of Health to optimize an induced pluripotent stem cell-derived cardiac fibroblast (iPSC-CF) technology to assemble Tandem™ HF biomaterial to facilitate heart failure treatment. The aim of this grant is to develop a second manufacturing pipeline of cardiac fibroblasts to manufacture Cellular Logistics’ novel Tandem™ HF biomaterial. iPSC-CF has the potential to offer a new predictable, renewable, and...
Cellular Logistics is one of 31 companies and nonprofit organizations selected as finalists for the 2019 Wisconsin Innovation Awards. In total, over 400 businesses, products and services from around the state were nominated. The finalists were determined by a panel of 21 statewide industry experts. Nominations...
Madison, WI., October 1, 2019 – UW-Madison physician researchers Amish Raval, M.D., and Tim Kamp, M.D., Ph.D., have been awarded a U01 Research Project Cooperative Agreement by The National Institutes of Health. Cellular Logistics, a UW spinout co-founded by Dr. Raval that is creating a...
To read the article click here....
MADISON, Wis., June 25, 2019 – Cellular Logistics today announced the publication of an article in Nature Communications that details of a cell-production advancement with significant positive implications for the commercialization of the company’s Tandem™ technology. The article, titled Functional cardiac fibroblasts derived from human...
To read the article click here to go to the Wisconsin State Journal....
MADISON, Wis., May 7, 2019 – Cellular Logistics Inc., the UW-Madison spinoff focused on delivering new ways to treat heart failure and restore heart function, today announced the appointment of Alex Vodenlich as president and chief executive. Mr. Vodenlich also will join the company’s board...
Cellular Logistics Founder, Dr. Amish Raval, has been awarded $107,000 from the State Economic Engagement and Development (SEED) Research Program for a proposal entitled, "Bioengineered Injectable Matrix to Improve Stem Cell Retention for Heart Repair." The press release can be viewed here....
Cellular Logistics CEO Rick Soni will be one of the expert panelists talking about early stage funding pitches at the Biotechnology Entrepreneurship Bootcamp in Boston. ...